IDMC Recommends Tonix Pharma To Stop Enrollment In Fibromyalgia Trial; Shares DropBenzinga • 07/26/21
Tonix Pharmaceuticals Announces Outcome of Interim Analysis of Phase 3 RALLY Study of TNX-102 SL for the Management of FibromyalgiaGlobeNewsWire • 07/23/21
Tonix Pharma Stock Moving Higher On Plans For Vaccine Manufacturing Facility In Bitterroot ValleyBenzinga • 06/25/21
Tonix Pharmaceuticals Announces Program to Develop TNX-102 SL for the Treatment of Long COVID Syndrome, also Known as Post-Acute Sequelae of COVID-19 (PASC)GlobeNewsWire • 06/21/21
Tonix Pharmaceuticals to Present at Raymond James Human Health Innovation ConferenceGlobeNewsWire • 06/16/21
Tonix Pharma Fibromyalgia Treatment Associated with Improvement in Pain, Sleep, FatigueBenzinga • 06/03/21
Tonix Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational HighlightsGlobeNewsWire • 05/10/21
Tonix Pharma: Interesting Molecule In Fibromyalgia, But Generic Availability Is A ConcernSeeking Alpha • 05/02/21
Tonix Pharmaceuticals to Participate in Fourth Annual Neuroscience Innovation ForumGlobeNewsWire • 04/21/21